DaVita, former CEO indicted in federal market collusion case -
DaVita and the company’s former CEO, Kent Thiry, were alleged to have conspired with Surgical Care Affiliates to suppress competition for senior-level employees between 2012 and 2017. SCA was indicted for collusion with several other healthcare organizations in Jan. The federal grand jury also returned an indictment alleging DaVita and Thiry had another no-poach agreement with an unnamed healthcare company between 2017 and 2019. A spokesperson for Thiry denied the accusations, saying no antitrust violations occurred.
Please see full publication below for more information.